Deeter Investments LLP’s iShares Biotechnology ETF IBB Stock Holding History

Deeter Investments LLP’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.03M	Buy	+12,000	New	+$1.95M	0.43%	42

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Deeter Investments LLP's IBB Position: Q4 2025 in Review

Deeter Investments LLP opened a new position in iShares Biotechnology ETF (IBB) in Q4 2025: 12,000 shares worth $2.03M. The stake represents 0.43% of the portfolio and ranks #42 among its holdings.

958 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

Deeter Investments LLP held 12,000 shares of iShares Biotechnology ETF worth $2.03M as of Q4 2025.
iShares Biotechnology ETF was a new Deeter Investments LLP position in Q4 2025.
iShares Biotechnology ETF made up 0.43% of Deeter Investments LLP's portfolio in Q4 2025, its #42 holding.
958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Deeter Investments LLP's 13F filing for Q4 2025, filed 28 Aug 2026.